Tumor weight/volume was much higher in mice injected with 4T1/COX-2+ TAMs, while lower in mice injected with 4T1/COX-2− TAMs than that in mice injected with 4T1/normal TAMs (Figure 2C). This evidence concerns the gene PTGS2 and neoplasm.